Beilai Bio

About:

Beilai Bio biopharmaceutical company focusing on the development of stem cell therapeutics for different diseases

Website: https://www.baylxinc.com

Top Investors: SDIC Venture Capital, DT Capital Partners, Huajin Capital, Nanjing Jiangbei New Area Industrial Investment Group

Description:

Beilai Bio is a clinical-stage biopharmaceutical company focused on the development of stem cell therapeutics for various diseases, particularly those with high unmet medical needs. Its established technology platforms allow them to produce clinical-grade "off-the-shelf" Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC) from an unlimited supply of cord tissues that are traditionally regarded as medical waste.